Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biochimica Et Biophysica Acta
|
August 8, 2012
Bone defects in LPA receptor genetically modified mice
Jean Pierre Salles, Sara Laurencin-Dalicieux, Françoise Conte-Auriol, et al.
Hormone Research
|
June 12, 2004
Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis
Maithé Tauber, Françoise Conte Auriol, Pierre Moulin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2008
Hyperghrelinemia precedes obesity in Prader-Willi syndrome
Eva Feigerlová, Gwenaëlle Diene, Françoise Conte-Auriol, et al.
The Journal of Clinical Investigation
|
November 13, 2009
LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice
Thierry Touvier, Françoise Conte-Auriol, Olivier Briand, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 7, 2015
Muscle and Bone Impairment in Children With Marfan Syndrome: Correlation With Age and FBN1 Genotype
Elsa Haine, Jean-Pierre Salles, Philippe Khau Van Kien, et al.
European Journal of Human Genetics : EJHG
|
June 12, 2014
Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome
Eric Bieth, Sanaa Eddiry, Véronique Gaston, et al.
Cell and Tissue Research
|
April 20, 2007
Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro
Philippe Kémoun, Sara Laurencin-Dalicieux, Jacqueline Rue, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 27, 2021
SNORD116 and growth hormone therapy impact IGFBP7 in Prader-Willi syndrome
Sanaa Eddiry, Gwenaelle Diene, Catherine Molinas, et al.
Bone
|
May 17, 2011
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass
Isabelle Gennero, Sara Laurencin-Dalicieux, Françoise Conte-Auriol, et al.
BMC Systems Biology
|
March 3, 2017
Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction
Theofilos Papadopoulos, Audrey Casemayou, Eric Neau, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biochimica Et Biophysica Acta
|
August 8, 2012
Bone defects in LPA receptor genetically modified mice
Jean Pierre Salles, Sara Laurencin-Dalicieux, Françoise Conte-Auriol, et al.
Hormone Research
|
June 12, 2004
Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis
Maithé Tauber, Françoise Conte Auriol, Pierre Moulin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2008
Hyperghrelinemia precedes obesity in Prader-Willi syndrome
Eva Feigerlová, Gwenaëlle Diene, Françoise Conte-Auriol, et al.
The Journal of Clinical Investigation
|
November 13, 2009
LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice
Thierry Touvier, Françoise Conte-Auriol, Olivier Briand, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 7, 2015
Muscle and Bone Impairment in Children With Marfan Syndrome: Correlation With Age and FBN1 Genotype
Elsa Haine, Jean-Pierre Salles, Philippe Khau Van Kien, et al.
European Journal of Human Genetics : EJHG
|
June 12, 2014
Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome
Eric Bieth, Sanaa Eddiry, Véronique Gaston, et al.
Cell and Tissue Research
|
April 20, 2007
Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro
Philippe Kémoun, Sara Laurencin-Dalicieux, Jacqueline Rue, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 27, 2021
SNORD116 and growth hormone therapy impact IGFBP7 in Prader-Willi syndrome
Sanaa Eddiry, Gwenaelle Diene, Catherine Molinas, et al.
Bone
|
May 17, 2011
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass
Isabelle Gennero, Sara Laurencin-Dalicieux, Françoise Conte-Auriol, et al.
BMC Systems Biology
|
March 3, 2017
Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction
Theofilos Papadopoulos, Audrey Casemayou, Eric Neau, et al.
Page
of 2